spironolactone has been researched along with Intestinal Pseudo-Obstruction in 1 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Intestinal Pseudo-Obstruction: A type of ILEUS, a functional not mechanical obstruction of the INTESTINES. This syndrome is caused by a large number of disorders involving the smooth muscles (MUSCLE, SMOOTH) or the NERVOUS SYSTEM.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sundar, U | 1 |
Lakkas, Y | 1 |
Asole, D | 1 |
Vaidya, M | 1 |
1 other study available for spironolactone and Intestinal Pseudo-Obstruction
Article | Year |
---|---|
Gitelman's syndrome presenting as recurrent paralytic ileus due to chronic renal tubular K+ wasting.
Topics: Alkalosis; Bartter Syndrome; Calcium; Chronic Disease; Diagnosis, Differential; Diuretics; Gitelman | 2010 |